These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells. Smollich M; Götte M; Fischgräbe J; Radke I; Kiesel L; Wülfing P Anticancer Res; 2009 Jun; 29(6):2167-71. PubMed ID: 19528477 [TBL] [Abstract][Full Text] [Related]
5. The expression of aromatase, estrogen receptor alpha and estrogen receptor beta in mouse Leydig cells in vitro that derived from cryptorchid males. Kotula-Balak M; Gancarczyk M; Sadowska J; Bilinskai B Eur J Histochem; 2005; 49(1):59-62. PubMed ID: 15823796 [TBL] [Abstract][Full Text] [Related]
6. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Hershberger PA; Vasquez AC; Kanterewicz B; Land S; Siegfried JM; Nichols M Cancer Res; 2005 Feb; 65(4):1598-605. PubMed ID: 15735050 [TBL] [Abstract][Full Text] [Related]
8. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis. Marchese S; Silva E PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216 [TBL] [Abstract][Full Text] [Related]
9. Genetic variants of estrogen beta and leptin receptors may cause gynecomastia in adolescent. Eren E; Edgunlu T; Korkmaz HA; Cakir ED; Demir K; Cetin ES; Celik SK Gene; 2014 May; 541(2):101-6. PubMed ID: 24625355 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-positive (ER Ferreira Almeida C; Oliveira A; João Ramos M; Fernandes PA; Teixeira N; Amaral C Biochem Pharmacol; 2020 Jul; 177():113989. PubMed ID: 32330493 [TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Mollerup S; Jørgensen K; Berge G; Haugen A Lung Cancer; 2002 Aug; 37(2):153-9. PubMed ID: 12140138 [TBL] [Abstract][Full Text] [Related]
12. Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol. Gorska M; Wyszkowska RM; Kuban-Jankowska A; Wozniak M Anticancer Res; 2016 May; 36(5):2217-26. PubMed ID: 27127126 [TBL] [Abstract][Full Text] [Related]
13. Expression of the estrogen receptors and steroidogenic enzymes involved in estradiol formation in the monkey vagina. Bertin J; Ouellet J; Dury AY; Pelletier G; Labrie F Am J Obstet Gynecol; 2014 Nov; 211(5):499.e1-9. PubMed ID: 24928055 [TBL] [Abstract][Full Text] [Related]
14. Expression and localization of aromatase P450AROM, estrogen receptor-α, and estrogen receptor-β in the developing fetal bovine frontal cortex. Peruffo A; Giacomello M; Montelli S; Corain L; Cozzi B Gen Comp Endocrinol; 2011 Jun; 172(2):211-7. PubMed ID: 21397601 [TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities. Munoz J; Wheler J; Kurzrock R Cancer Metastasis Rev; 2015 Dec; 34(4):547-61. PubMed ID: 25543191 [TBL] [Abstract][Full Text] [Related]
16. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876 [TBL] [Abstract][Full Text] [Related]
17. Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression. Tang H; Liao Y; Zhang C; Chen G; Xu L; Liu Z; Fu S; Yu L; Zhou S Oncol Res; 2014; 22(1):13-20. PubMed ID: 25700354 [TBL] [Abstract][Full Text] [Related]
18. Increased levels of enzymes involved in local estradiol synthesis in chronic obstructive pulmonary disease. Konings GFJ; Reynaert NL; Delvoux B; Verhamme FM; Bracke KR; Brusselle GG; Romano A; Vernooy JHJ Mol Cell Endocrinol; 2017 Mar; 443():23-31. PubMed ID: 27940297 [TBL] [Abstract][Full Text] [Related]
19. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Nair HB; Luthra R; Kirma N; Liu YG; Flowers L; Evans D; Tekmal RR Cancer Res; 2005 Dec; 65(23):11164-73. PubMed ID: 16322267 [TBL] [Abstract][Full Text] [Related]
20. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines. Shen L; Li Z; Shen S; Niu X; Yu Y; Li Z; Liao M; Chen Z; Lu S Lung Cancer; 2012 Dec; 78(3):193-200. PubMed ID: 22985911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]